129 related articles for article (PubMed ID: 37487908)
1. Treatment Individualization in Diffuse Large B-Cell Lymphoma: Is Frailty Enough for Old Adults? An Original Article.
García-Baztán A; Oteiza-Olaso J; Gonzales-Montejo NJ; Ramón-Espinoza MF; Tamayo-Rodríguez I; Martínez-Velilla N; Viguria-Alegria MC
Clin Lymphoma Myeloma Leuk; 2023 Oct; 23(10):e348-e359. PubMed ID: 37487908
[TBL] [Abstract][Full Text] [Related]
2. Hand grip strength, short physical performance battery, and gait speed: key tools for function in Non-Hodgkin Lymphoma.
García-Baztán A; Viguria-Alegria MC; Ramón-Espinoza MF; Tamayo-Rodríguez I; Gonzales-Montejo NJ; Martínez-Velilla N; Oteiza-Olaso J
Ann Hematol; 2023 Oct; 102(10):2823-2834. PubMed ID: 37566279
[TBL] [Abstract][Full Text] [Related]
3. A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL.
Isaksen KT; Mastroianni MA; Rinde M; Rusten LS; Barzenje DA; Ramslien LF; Slaaen M; Jerm MB; Smeland EB; Rostoft S; Liestøl K; Brodtkorb M; Holte H
Blood Adv; 2021 Nov; 5(22):4771-4782. PubMed ID: 34543384
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Geriatric Assessment (CGA): A Simple Tool for Guiding the Treatment of Older Adults with Diffuse Large B-Cell Lymphoma in China.
Bai JF; Han HX; Feng R; Li JT; Wang T; Zhang CL; Liu H
Oncologist; 2020 Aug; 25(8):e1202-e1208. PubMed ID: 32436258
[TBL] [Abstract][Full Text] [Related]
5. Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study.
Yhim HY; Park Y; Kim JA; Shin HJ; Do YR; Moon JH; Kim MK; Lee WS; Kim DS; Lee MW; Choi YS; Jeong SH; Kim KH; Kim J; Lee CH; Song GY; Yang DH; Kwak JY
Korean J Intern Med; 2024 May; 39(3):501-512. PubMed ID: 38287501
[TBL] [Abstract][Full Text] [Related]
6. Diffuse Large B-Cell Lymphoma in the Elderly: Current Approaches.
Allen P
Curr Oncol Rep; 2020 Aug; 22(11):114. PubMed ID: 32827063
[TBL] [Abstract][Full Text] [Related]
7. Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma.
Yagi Y; Kanemasa Y; Sasaki Y; Goto S; Yamamura Y; Ishimine K; Hayashi Y; Mino M; Ohigashi A; Morita Y; Tamura T; Nakamura S; Okuya T; Shimoyama T
Ann Hematol; 2023 Jun; 102(6):1485-1500. PubMed ID: 37115298
[TBL] [Abstract][Full Text] [Related]
8. Frontline treatment of diffuse large B-cell lymphoma in elderly: a systematic review of clinical trials in post-rituximab era.
Beygi S; Sadashiv S; Reilly JB; Khan C; Lister J
Leuk Lymphoma; 2018 Dec; 59(12):2847-2861. PubMed ID: 29616868
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B-cell lymphoma receiving rituximab-chemotherapy combinations.
Ong DM; Ashby M; Grigg A; Gard G; Ng ZY; Huang HE; Chong YS; Cheah CY; Devitt B; Chong G; Loh Z; Mo A; Hawkes EA
Br J Haematol; 2019 Oct; 187(1):73-81. PubMed ID: 31206608
[TBL] [Abstract][Full Text] [Related]
10. Diffuse large B-cell lymphoma in very elderly patients: Towards best tailored treatment - A systematic review.
Tavares A; Moreira I
Crit Rev Oncol Hematol; 2021 Apr; 160():103294. PubMed ID: 33675907
[TBL] [Abstract][Full Text] [Related]
11. Electronic FRAIL score as a predictor of treatment outcomes in older patients with diffuse large B-cell lymphoma.
Zhang J; Disperati P; Elinder-Camburn A; Merriman E; Leitch S; Chan H
J Geriatr Oncol; 2022 May; 13(4):505-510. PubMed ID: 34906444
[TBL] [Abstract][Full Text] [Related]
12. SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas - Aiming to improve therapy, outcomes, and validate a prospective frailty tool.
Brem EA; Li H; Beaven AW; Caimi PF; Cerchietti L; Alizadeh AA; Olin R; Henry NL; Dillon H; Little RF; Laubach C; LeBlanc M; Friedberg JW; Smith SM
J Geriatr Oncol; 2022 Mar; 13(2):258-264. PubMed ID: 34686472
[TBL] [Abstract][Full Text] [Related]
13. Measuring frailty in clinical practice: a comparison of physical frailty assessment methods in a geriatric out-patient clinic.
Pritchard JM; Kennedy CC; Karampatos S; Ioannidis G; Misiaszek B; Marr S; Patterson C; Woo T; Papaioannou A
BMC Geriatr; 2017 Nov; 17(1):264. PubMed ID: 29132301
[TBL] [Abstract][Full Text] [Related]
14. Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi.
Merli F; Luminari S; Rossi G; Mammi C; Marcheselli L; Ferrari A; Spina M; Tucci A; Stelitano C; Capodanno I; Fragasso A; Baldini L; Bottelli C; Montechiarello E; Fogazzi S; Lamorgese C; Cavalli L; Federico M;
Leuk Lymphoma; 2014 Jan; 55(1):38-43. PubMed ID: 23517562
[TBL] [Abstract][Full Text] [Related]
15. A Host-Dependent Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma.
Miura K; Konishi J; Miyake T; Makita M; Hojo A; Masaki Y; Uno M; Ozaki J; Yoshida C; Niiya D; Kitazume K; Maeda Y; Takizawa J; Sakai R; Yano T; Yamamoto K; Sunami K; Hiramatsu Y; Aoyama K; Tsujimura H; Murakami J; Hatta Y; Kanno M
Oncologist; 2017 May; 22(5):554-560. PubMed ID: 28408622
[TBL] [Abstract][Full Text] [Related]
16. Treating Diffuse Large B Cell Lymphoma in the Very Old or Frail Patients.
Kumar A; Fraz MA; Usman M; Malik SU; Ijaz A; Durer C; Durer S; Tariq MJ; Khan AY; Qureshi A; Faridi W; Nasar A; Anwer F
Curr Treat Options Oncol; 2018 Sep; 19(10):50. PubMed ID: 30173370
[TBL] [Abstract][Full Text] [Related]
17. Physical frailty in patients with systemic sclerosis.
Hax V; Tessari J; Pena E; Santo RCDE; Dos Santos LP; Gasparin AA; Bredemeier M; Fighera TM; Spritzer PM; Xavier RM; Chakr RMDS
Semin Arthritis Rheum; 2022 Oct; 56():152077. PubMed ID: 35952534
[TBL] [Abstract][Full Text] [Related]
18. R-CVP regimen is active in frail elderly patients aged 80 or over with diffuse large B cell lymphoma.
Laribi K; Denizon N; Bolle D; Truong C; Besançon A; Sandrini J; Anghel A; Farhi J; Ghnaya H; Baugier de Materre A
Ann Hematol; 2016 Oct; 95(10):1705-14. PubMed ID: 27485454
[TBL] [Abstract][Full Text] [Related]
19. A 10-Item Frailty Index Based on a Comprehensive Geriatric Assessment (FI-CGA-10) in Older Adults with Cancer: Development and Construct Validation.
Nishijima TF; Shimokawa M; Esaki T; Morita M; Toh Y; Muss HB
Oncologist; 2021 Oct; 26(10):e1751-e1760. PubMed ID: 34216413
[TBL] [Abstract][Full Text] [Related]
20. Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma.
Miura K; Takahashi H; Nakagawa M; Hamada T; Uchino Y; Iizuka K; Ohtake S; Iriyama N; Hatta Y; Nakamura H
Expert Rev Anticancer Ther; 2022 Jun; 22(6):583-595. PubMed ID: 35472312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
